Shkreli Pleads Not Guilty to Hiding Retrophin Holdings

  • Company founder, ex-lawyer Greebel face new conspiracy charge
  • Former drug company CEO accused of masking control of stock

Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York, on June 6, in Brooklyn.

Photographer: Drew Angerer/Getty Images

Former drug company executive Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.